Supplemental Annuity Collective Trust Of Nj Viking Therapeutics, Inc. Transaction History
Supplemental Annuity Collective Trust Of Nj
- $348 Million
- Q2 2025
Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
448Shares Held
66.9MCall Options Held
7.9MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$405 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$240 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$150 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$125 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.12MShares$124 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.06B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...